GAAPP is pleased to announce their support of the new and innovative Program I-START (Integrated Solutions for Targeted AlleRgy Treatment) developed together with Stallergenes Greer.
I-START aims to improve access to information about appropriate medical care for people living with respiratory allergies.
It was developed on the principle that people suffering from respiratory allergies face multiple barriers to optimal medical care, including under-diagnosis, poor recognition of the impact of allergy on their health and daily lives, and limited awareness of available treatment options.
I-START consequently aims to improve the care of those living with respiratory allergies by:
- Connecting and empowering all relevant stakeholders.
- Providing access to up-to-date and relevant information.
To learn more about the programme, please access the webpage: